IRiva Medical Secures Initial Funding Round Led by F-Prime

Why It Matters

The funding and seasoned leadership give iRiva the resources and expertise to accelerate development of neuromodulation therapies, a high‑growth segment of med‑tech, while underscoring investor confidence in accelerator‑sourced startups. Successful commercialization could address unmet needs for chronic disease management and generate significant market upside.

Deal Summary

Minneapolis‑based iRiva Medical announced the close of its initial financing round, led by F‑Prime with participation from Hatteras Venture Partners, Norwest and Treo Ventures. The undisclosed amount will fund the development and commercialization of its neuromodulation technology platforms.